Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript
Inv. presentation
Director departure
Appointed director

WINDTREE THERAPEUTICS INC (WINT) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/25/2023 4 Williams Leslie J. (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns: Granted 2,033 shares @ $0
Granted 3,050 options to buy @ $1.21, valued at $3.7k
08/25/2023 4 Strobeck Mark (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns: Granted 2,300 shares @ $0
Granted 3,450 options to buy @ $1.21, valued at $4.2k
08/25/2023 4 SCOTT ROBERT A (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns: Granted 2,033 shares @ $0
Granted 3,050 options to buy @ $1.21, valued at $3.7k
08/25/2023 4 Simonson Steven (SVP, Chief Medical Officer) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns: Granted 15,867 shares @ $0
Granted 23,800 options to buy @ $1.21, valued at $28.8k
08/25/2023 4 Curtis Eric (SVP & COO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns: Granted 14,667 shares @ $0
Granted 22,000 options to buy @ $1.21, valued at $26.6k
08/25/2023 4 Fraser Craig (President and CEO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns: Granted 45,867 shares @ $0
Granted 68,800 options to buy @ $1.21, valued at $83.2k
08/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: " "
08/07/2023 8-K Quarterly results
Docs: " "
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
06/28/2023 3 Strobeck Mark (Director) has filed a Form 3 on WINDTREE THERAPEUTICS INC /DE/
05/31/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/19/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/19/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
05/17/2023 SC 13D/A Huang James reports a 1.5% stake in Windtree Therapeutics, Inc.
05/01/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
04/28/2023 SC 13G Lind Global Fund II LP reports a 9.9% stake in Windtree Therapeutics, Inc.
04/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/24/2023 8-K Quarterly results
04/24/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/20/2023 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
04/20/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/19/2023 S-1MEF Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
04/19/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/19/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
04/19/2023 8-K Quarterly results
04/13/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
04/13/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
04/03/2023 8-K Quarterly results
Docs: " ",
" "
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
03/02/2023 4 Simonson Steven (SVP, Chief Medical Officer) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns: Paid exercise price by delivering 100 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy